“…Reports on the overall outcome of SAH can be classified broadly into those from epidemiological studies and those from referral centers or large-scale cooperative studies, but differences between them are apparent [2, 12, 13, 17, 30, 31, 32, 33, 39, 40, 41, 42, 43, 44]. According to community-based studies other than that from Izumo, 3–21% of patients with SAH died before receiving medical attention [45]and overall case fatality rates were 15–42% in the first week [1, 8, 11, 15, 25, 43], 33–54% at 3 weeks [2, 11, 46, 47], 20–61% at 1 month [8, 10, 11, 12, 13, 14, 16, 25, 30, 31, 32, 33, 39, 42, 43, 44, 48, 49, 50, 51], 29–44% at 6 months [11, 14, 52]and 33–77% at 1 year [8, 11, 25, 30, 39, 42, 44, 48].…”